ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NTP Board Approves Six New Projects, Tables One Other

January 23, 1981

In Brief: Medical School Deans Biggest Enemy Of Cancer Program, Saunders Says; House Oks Line Item

May 16, 1980

Grants Funding; NCI Restores Paylines To Last Year’s Levels

July 4, 1997

Three Scientists Win Albert Lasker Medial Research Awards

September 30, 1994

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998

Highlights of Dingell Hearing: Statements Of Visco, Testimony By Broder On Fisher, Uterine Cancer Deaths

April 22, 1994